Publicacións nas que colabora con Bartolomé Burguera González (16)

2016

  1. Short-Term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus

    Nutrition and Diabetes, Vol. 6, Núm. 9, pp. e230

2014

  1. White fish reduces cardiovascular risk factors in patients with metabolic syndrome: The WISH-CARE study, a multicenter randomized clinical trial

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 3, pp. 328-335

2013

  1. Weight-related quality of life in spanish obese subjects suitable for bariatric surgery is lower than in their north american counterparts: A case-control study

    Obesity Surgery, Vol. 23, Núm. 4, pp. 509-514

2007

  1. Critical assessment of the current guidelines for the management and treatment of morbidly obese patients

    Journal of Endocrinological Investigation, Vol. 30, Núm. 10, pp. 844-852

1993

  1. Regulation of his-dtrp-ala-trp- dphe-lys-NH2 (GHRP-6)-lnduced GH secretion in the ratabstract

    Neuroendocrinology, Vol. 57, Núm. 2, pp. 246-256

1992

  1. Corticoids as a new stimulus of growth hormone secretion in man

    Journal of Pediatric Endocrinology and Metabolism, Vol. 5, Núm. 1-2, pp. 85-90

1991

  1. Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat

    Neuroendocrinology, Vol. 53, Núm. 2, pp. 185-189

  2. Lack of effect of TRH secretion of growth hormone induced by dexamethasone

    Revista Clinica Espanola, Vol. 188, Núm. 2, pp. 65-67

1990

  1. Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man

    Neuroendocrinology, Vol. 51, Núm. 1, pp. 51-58

  2. Estrogen-dependent effects of bombesin on in vivo growth hormone secretion in the rat

    Neuroendocrinology, Vol. 52, Núm. 6, pp. 608-611

  3. Neuroregulation of GH secretion in obesity

    Recent Advances in growth and reproduction (Servicio de Publicaciones e Intercambio Científico), pp. 93-103

1989

  1. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: Does acute hyperglycemia act through hypothalamic release of somatostatin?

    Neuroendocrinology, Vol. 49, Núm. 5, pp. 551-554

  2. Administration of glucocorticoids and growth hormone (GH) secretion in man

    Recent advances in basic and clinical neuroendocrinology: proceedings of the 4th Meeting of the European Neuroendocrine Association. ICS864

1988

  1. Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man

    Neuroendocrinology, Vol. 47, Núm. 1, pp. 46-49

1987

  1. GROWTH HORMONE AND PROLACTIN SECRETION AFTER GROWTH HORMONE‐RELEASING HORMONE ADMINISTRATION, IN ANOREXIA NERVOSA PATIENTS, NORMAL CONTROLS AND TAMOXIFEN‐PRETREATED VOLUNTEERS

    Clinical Endocrinology, Vol. 27, Núm. 5, pp. 517-523

  2. Steroids and neuroendocrine function in anorexia nervosa

    Journal of Steroid Biochemistry, Vol. 27, Núm. 1-3, pp. 635-640